Navigation Links
Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2009 Results
Date:4/23/2009

GLENWOOD, Ill., April 23 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal second quarter of 2009 pre-market on Tuesday, May 5, 2009.

The company will host a conference call for investors on Tuesday, May 5, 2009, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 877-941-1469 (within the United States and Canada), or 480-629-9675 (international callers), and referencing the conference ID #4064265, or by visiting the "Investors" page on the company's website at www.landauerinc.com. Please log on to the website at least 15 minutes early to register, download and install any necessary audio software.

Investors may access a replay of the call by dialing 800-406-7325 (within the United States and Canada), or 303-590-3030 (international callers), passcode 4064265#, which will be available through 12:00 a.m. on June 4, 2009. The replay will also be available on Landauer's website for 90 days following the call.

About Landauer

Landauer is the leading provider of analytical services to determine occupational and environmental radiation exposure. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.

For the latest news releases and other corporate documents on Landauer Inc., visit www.landauerinc.com


'/>"/>
SOURCE Landauer, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Landauer, Inc. Declares Regular Cash Dividend
2. Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results
3. Landauer, Inc. Declares Regular Cash Dividend
4. Landauer, Inc. Reports Record Results for Second Quarter
5. Landauer, Inc. Declares Regular Cash Dividend
6. Landauer, Inc. Declares Regular Cash Dividend
7. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2008 Results
8. Landauer, Inc. Increases Regular Cash Dividend and Declares First Quarter Payment
9. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2009 Results
10. Landauer, Inc. Declares Regular Cash Dividend
11. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, ... ... that develops a variety of unique liquid food supplements, announced its popular products ... of nutritional products. , ALP Nutrition® prioritizes the use of premium natural ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... (CDC), rising prescription opioid overdose deaths now claim the lives of 62 Americans ... civil case filings against drug manufacturers, distributors, pharmacies and prescribers by more than ...
(Date:4/24/2017)... , ... April 24, 2017 , ... As a former ... a thousand words. The good news for single women is that she put all ... is available on April 25th. Joan's insight, personal experiences and sparkling sense of humor ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Reflections of God’s Work”: ... “Reflections of God’s Work” is the creation of published author, Jerri Broglin, a survivor ... , “I believe this a great eye-opener for those searching for answers, as ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... brands, work wear distributors and International relief organizations across the globe to provide ... also offers lifestyle and work wear collections via insectshield.com . In the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: